← Back to Search

Health Education & Support for Lung Cancer

N/A
Recruiting
Led By Ashley E Prosper
Research Sponsored by Jonsson Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Breast screening > 40
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Study Summary

This trial will assess how advocates and supporters of breast and lung cancer screening can improve lung cancer screening rates. It also looks at the psychological barriers to cancer screening.

Who is the study for?
This trial is for people eligible for breast (over 40 years old) and lung cancer screening (ages 50-80), regardless of smoking status. Participants can be male or female and should have a close family or friend with a history of smoking. It excludes those under the age limits, previously diagnosed with lung cancer, recent unexplained weight loss, hemoptysis, or active cancer.Check my eligibility
What is being tested?
The study tests if using advocates and supporters can increase lung cancer screening rates among eligible individuals. It involves health education programs, patient navigation services to guide through healthcare systems, and survey administration to gather data on psychological barriers unique to lung screening.See study design
What are the potential side effects?
Since this trial focuses on educational interventions rather than medical treatments, there are no direct side effects like you would expect from drugs or surgeries. However, participants may experience discomfort discussing personal health issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 40 and have had a breast screening.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Increased rates of lung and breast cancer screening adherence
Secondary outcome measures
Success of "sphere of influence" model

Trial Design

1Treatment groups
Experimental Treatment
Group I: Screening (electronic patient portal, patient navigation)Experimental Treatment4 Interventions
Participants access an electronic patient portal with educational materials at baseline, 1- and 2-year follow-ups, and also interact with a patient navigator on study. Patients also receive materials to share with their friends/family on benefits of breast and lung cancer screening on study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Health Education
2014
Completed Phase 3
~4010
Patient Navigation
2017
Completed Phase 2
~38910

Find a Location

Who is running the clinical trial?

Jonsson Comprehensive Cancer CenterLead Sponsor
361 Previous Clinical Trials
27,012 Total Patients Enrolled
24 Trials studying Breast Cancer
1,758 Patients Enrolled for Breast Cancer
Ashley E ProsperPrincipal InvestigatorUCLA / Jonsson Comprehensive Cancer Center

Media Library

Screening (electronic patient portal, patient navigation) Clinical Trial Eligibility Overview. Trial Name: NCT05978128 — N/A
Breast Cancer Research Study Groups: Screening (electronic patient portal, patient navigation)
Breast Cancer Clinical Trial 2023: Screening (electronic patient portal, patient navigation) Highlights & Side Effects. Trial Name: NCT05978128 — N/A
Screening (electronic patient portal, patient navigation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05978128 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it still possible to partake in this experiment?

"The information hosted on clinicaltrials.gov stipulates that this medical trial is not accepting participants currently, though the study was initially posted in September of 2023 and updated last in July of the same year. Although it's inactive at present, there are still 4733 other trials recruiting patients right now."

Answered by AI

Does this experiment permit older participants aged 55 and over?

"This experiment is enrolling individuals who are between 40 and 80 years old."

Answered by AI

Am I able to participate in this experiment?

"This clinical trial is recruiting 800 patients with breast cancer between the ages of 40 and 80."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
2023. "Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05978128.
~533 spots leftby Sep 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top